Off Patent August 2026
Tekturna
aliskiren hemifumarate
Lxo Ireland Designated Activity Co
Tablet (oral) · NDA 021985
Last listed protection ended
August 19, 2026
The FDA listed 1 patent for Tekturna, and this is the day the last one ended. It is not the date a generic goes on sale.
Patents and exclusivities
- EndedPatent 8,617,595Claims the drug product
- EndedPatent 8,617,595Pediatric extension: six more months